Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Sandesh Seth Insider Profile

4 Followers

Sandesh Seth, CEO, Director at Actinium Pharmaceuticals, holds 1.97M shares in Actinium Pharmaceuticals (Ticker: ATNM).

Sandesh Seth's Trading History

ATNMActinium Pharmaceuticals		Sep 04, 2026CEO, DirectorUninformative Buy―$2.91M
ATNM
Insider Shares: 1.97M (6.25%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Sep 04, 2026Uninformative Buy$0.001,780,874$0.00―
Aug 20, 2025Uninformative Sell$206.74K120,900$1.71―
Aug 19, 2022Uninformative Buy$0.00300,000$0.00―
Feb 21, 2019Informative Buy$4.88K8,125$0.60-57.90%
Dec 10, 2018Informative Buy$4.30K10,000$0.43-50.30%
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Sandesh Seth insider profile FAQ

What is the percentage of profitable transactions made by Sandesh Seth?
The percentage of profitable transactions made by Sandesh Seth is 0%.
What is the average return per transaction made by Sandesh Seth?
The average return per transaction made by Sandesh Seth is -37.90%.
What stocks does Sandesh Seth hold?
Sandesh Seth holds: ATNM stocks.
What was Sandesh Seth's most profitable transaction?
Sandesh Seth’s most profitable transaction was an Informative Buy of ATNM stock on August 4, 2017. The return on the trade was -5.70%.
What is Sandesh Seth's role in Actinium Pharmaceuticals?
Sandesh Seth's role in Actinium Pharmaceuticals is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.